Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Meningococcal Group B Vaccine industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Pfizer
GSK
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Type 1
Type 2
Application:
Public
Private
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Meningococcal Group B Vaccine Industry Overview
-
1.1.1 Meningococcal Group B Vaccine Market Scope and Market Segments
-
1.1.2 Meningococcal Group B Vaccine Industry Characteristics
-
1.1.3 Global and China Meningococcal Group B Vaccine Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Meningococcal Group B Vaccine Production Value and Growth Rate (2017-2028)
-
1.2 Global Meningococcal Group B Vaccine Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Type 1
-
1.2.2 Type 2
-
1.3 Global Meningococcal Group B Vaccine Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Public
-
1.3.2 Private
-
1.4 Market Analysis by Region
-
1.4.1 North America Meningococcal Group B Vaccine Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Meningococcal Group B Vaccine Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Meningococcal Group B Vaccine Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Meningococcal Group B Vaccine Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Meningococcal Group B Vaccine Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Meningococcal Group B Vaccine Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Meningococcal Group B Vaccine Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Meningococcal Group B Vaccine Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Meningococcal Group B Vaccine Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Meningococcal Group B Vaccine Industry Porter's Five Forces Model Analysis
-
2.2.3 Meningococcal Group B Vaccine Industry PEST Analysis
-
2.3 Meningococcal Group B Vaccine Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Meningococcal Group B Vaccine Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Meningococcal Group B Vaccine Industry
Chapter 3 Global and China Meningococcal Group B Vaccine Market, by Manufacturer
-
3.1 Global and China Meningococcal Group B Vaccine Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Meningococcal Group B Vaccine Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Meningococcal Group B Vaccine Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Meningococcal Group B Vaccine Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Meningococcal Group B Vaccine Market Top 3 Players
Chapter 4 Global and China Meningococcal Group B Vaccine Market, by Type (2017-2028)
-
4.1 Meningococcal Group B Vaccine Market Trend, by Type
-
4.2 Global Meningococcal Group B Vaccine Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Meningococcal Group B Vaccine Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Meningococcal Group B Vaccine Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Meningococcal Group B Vaccine Price Trend, by Type (2017-2028)
-
4.3 China Meningococcal Group B Vaccine Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Meningococcal Group B Vaccine Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Meningococcal Group B Vaccine Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Meningococcal Group B Vaccine Price Trend, by Type (2017-2028)
Chapter 5 Global and China Meningococcal Group B Vaccine Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Meningococcal Group B Vaccine Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Meningococcal Group B Vaccine Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Meningococcal Group B Vaccine Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Meningococcal Group B Vaccine Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Meningococcal Group B Vaccine Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Meningococcal Group B Vaccine Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Meningococcal Group B Vaccine Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Meningococcal Group B Vaccine Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Meningococcal Group B Vaccine Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Meningococcal Group B Vaccine Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Meningococcal Group B Vaccine Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Meningococcal Group B Vaccine Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Meningococcal Group B Vaccine Market Analysis
-
7.1 North America Meningococcal Group B Vaccine Market, by Type
-
7.2 North America Meningococcal Group B Vaccine Market, by Application
-
7.3 North America Meningococcal Group B Vaccine Market Analysis and Forecast, by Country
-
7.3.1 United States Meningococcal Group B Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Meningococcal Group B Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Meningococcal Group B Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Meningococcal Group B Vaccine Market Analysis
-
8.1 Europe Meningococcal Group B Vaccine Market, by Type
-
8.2 Europe Meningococcal Group B Vaccine Market, by Application
-
8.3 Europe Meningococcal Group B Vaccine Market Analysis and Forecast, by Country
-
8.3.1 Germany Meningococcal Group B Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Meningococcal Group B Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Meningococcal Group B Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Meningococcal Group B Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Meningococcal Group B Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Meningococcal Group B Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Meningococcal Group B Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Meningococcal Group B Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Meningococcal Group B Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Meningococcal Group B Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Meningococcal Group B Vaccine Market Analysis
-
9.1 APAC Meningococcal Group B Vaccine Market, by Type
-
9.2 APAC Meningococcal Group B Vaccine Market, by Application
-
9.3 APAC Meningococcal Group B Vaccine Market Analysis and Forecast, by Country
-
9.3.1 China Meningococcal Group B Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Meningococcal Group B Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Meningococcal Group B Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Meningococcal Group B Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Meningococcal Group B Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Meningococcal Group B Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Meningococcal Group B Vaccine Market Analysis
-
10.1 Latin America, Middle East and Africa Meningococcal Group B Vaccine Market, by Type
-
10.2 Latin America, Middle East and Africa Meningococcal Group B Vaccine Market, by Application
-
10.3 Latin America, Middle East and Africa Meningococcal Group B Vaccine Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Meningococcal Group B Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Meningococcal Group B Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Meningococcal Group B Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Meningococcal Group B Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Meningococcal Group B Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Meningococcal Group B Vaccine Company Profiles
-
11.1 Pfizer
-
11.1.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Pfizer Meningococcal Group B Vaccine Product Profiles, Application and Specification
-
11.1.3 Pfizer Meningococcal Group B Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 GSK
-
11.2.1 GSK Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 GSK Meningococcal Group B Vaccine Product Profiles, Application and Specification
-
11.2.3 GSK Meningococcal Group B Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Meningococcal Group B Vaccine Industry Investment Prospect and Risk Assessment
-
12.1 Meningococcal Group B Vaccine Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Meningococcal Group B Vaccine Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Meningococcal Group B Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure China Meningococcal Group B Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure Global Meningococcal Group B Vaccine Production Value and Growth Rate (2017-2028)
-
Figure China Meningococcal Group B Vaccine Production Value and Growth Rate (2017-2028)
-
Figure Global Meningococcal Group B Vaccine Market Size and Growth Rate of Type 1 (2017-2028)
-
Figure Global Meningococcal Group B Vaccine Market Size and Growth Rate of Type 2 (2017-2028)
-
Figure Global Meningococcal Group B Vaccine Market Size and Growth Rate of Public (2017-2028)
-
Figure Global Meningococcal Group B Vaccine Market Size and Growth Rate of Private (2017-2028)
-
Figure North America Meningococcal Group B Vaccine Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Meningococcal Group B Vaccine Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Meningococcal Group B Vaccine Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Meningococcal Group B Vaccine Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Meningococcal Group B Vaccine Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Meningococcal Group B Vaccine Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Meningococcal Group B Vaccine Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Meningococcal Group B Vaccine Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Meningococcal Group B Vaccine Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Meningococcal Group B Vaccine Market Share, by Manufacturer in 2021
-
Figure Global and China Meningococcal Group B Vaccine Market Share, by Manufacturer in 2022
-
Table Global Meningococcal Group B Vaccine Sales Volume, by Type (2017-2028)
-
Table Global Meningococcal Group B Vaccine Sales Volume Share, by Type (2017-2028)
-
Figure Global Meningococcal Group B Vaccine Sales Volume Share, by Type (2017-2028)
-
Table Global Meningococcal Group B Vaccine Sales Value, by Type (2017-2028)
-
Table Global Meningococcal Group B Vaccine Sales Value Share, by Type (2017-2028)
-
Figure Global Meningococcal Group B Vaccine Price Trend, by Type (2017-2028)
-
Table China Meningococcal Group B Vaccine Sales Volume, by Type (2017-2028)
-
Table China Meningococcal Group B Vaccine Sales Volume Share, by Type (2017-2028)
-
Figure China Meningococcal Group B Vaccine Sales Volume Share, by Type (2017-2028)
-
Table China Meningococcal Group B Vaccine Sales Value, by Type (2017-2028)
-
Table China Meningococcal Group B Vaccine Sales Value Share, by Type (2017-2028)
-
Figure China Meningococcal Group B Vaccine Price Trend, by Type (2017-2028)
-
Table Global Meningococcal Group B Vaccine Sales Volume, by Application (2017-2028)
-
Table Global Meningococcal Group B Vaccine Sales Volume Share, by Application (2017-2028)
-
Figure Global Meningococcal Group B Vaccine Sales Volume Share, by Application (2017-2028)
-
Table Global Meningococcal Group B Vaccine Sales Value, by Application (2017-2028)
-
Table Global Meningococcal Group B Vaccine Sales Value Share, by Application (2017-2028)
-
Figure Global Meningococcal Group B Vaccine Sales Value Share, by Application (2017-2028)
-
Table China Meningococcal Group B Vaccine Sales Volume, by Application (2017-2028)
-
Table China Meningococcal Group B Vaccine Sales Volume Share, by Application (2017-2028)
-
Figure China Meningococcal Group B Vaccine Sales Volume Share, by Application (2017-2028)
-
Table China Meningococcal Group B Vaccine Sales Value, by Application (2017-2028)
-
Table China Meningococcal Group B Vaccine Sales Value Share, by Application (2017-2028)
-
Figure China Meningococcal Group B Vaccine Sales Value Share, by Application (2017-2028)
-
Figure China Meningococcal Group B Vaccine Production, Import, Consumption and Export (2017-2022)
-
Figure North America Meningococcal Group B Vaccine Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Meningococcal Group B Vaccine Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Meningococcal Group B Vaccine Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Meningococcal Group B Vaccine Production, Import, Consumption and Export (2017-2022)
-
Table North America Meningococcal Group B Vaccine Sales Volume, by Type (2017-2028)
-
Table North America Meningococcal Group B Vaccine Sales Volume Share, by Type (2017-2028)
-
Figure North America Meningococcal Group B Vaccine Sales Volume Share, by Type (2017-2028)
-
Table North America Meningococcal Group B Vaccine Sales Volume, by Application (2017-2028)
-
Table North America Meningococcal Group B Vaccine Sales Volume Share, by Application (2017-2028)
-
Figure North America Meningococcal Group B Vaccine Sales Volume Share, by Application (2017-2028)
-
Figure United States Meningococcal Group B Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure United States Meningococcal Group B Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure Canada Meningococcal Group B Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Meningococcal Group B Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Meningococcal Group B Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Meningococcal Group B Vaccine Sales Value and Growth Rate (2017-2028)
-
Table Europe Meningococcal Group B Vaccine Sales Volume, by Type (2017-2028)
-
Table Europe Meningococcal Group B Vaccine Sales Volume Share, by Type (2017-2028)
-
Figure Europe Meningococcal Group B Vaccine Sales Volume Share, by Type (2017-2028)
-
Table Europe Meningococcal Group B Vaccine Sales Volume, by Application (2017-2028)
-
Table Europe Meningococcal Group B Vaccine Sales Volume Share, by Application (2017-2028)
-
Figure Europe Meningococcal Group B Vaccine Sales Volume Share, by Application (2017-2028)
-
Figure Germany Meningococcal Group B Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Meningococcal Group B Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure UK Meningococcal Group B Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure UK Meningococcal Group B Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure France Meningococcal Group B Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure France Meningococcal Group B Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure Italy Meningococcal Group B Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Meningococcal Group B Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Meningococcal Group B Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Meningococcal Group B Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure Spain Meningococcal Group B Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Meningococcal Group B Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Meningococcal Group B Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Meningococcal Group B Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure Poland Meningococcal Group B Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Meningococcal Group B Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure Russia Meningococcal Group B Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Meningococcal Group B Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Meningococcal Group B Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Meningococcal Group B Vaccine Sales Value and Growth Rate (2017-2028)
-
Table APAC Meningococcal Group B Vaccine Sales Volume, by Type (2017-2028)
-
Table APAC Meningococcal Group B Vaccine Sales Volume Share, by Type (2017-2028)
-
Figure APAC Meningococcal Group B Vaccine Sales Volume Share, by Type (2017-2028)
-
Table APAC Meningococcal Group B Vaccine Sales Volume, by Application (2017-2028)
-
Table APAC Meningococcal Group B Vaccine Sales Volume Share, by Application (2017-2028)
-
Figure APAC Meningococcal Group B Vaccine Sales Volume Share, by Application (2017-2028)
-
Figure China Meningococcal Group B Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure China Meningococcal Group B Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure Japan Meningococcal Group B Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Meningococcal Group B Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Meningococcal Group B Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Meningococcal Group B Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure India Meningococcal Group B Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure India Meningococcal Group B Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Meningococcal Group B Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Meningococcal Group B Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Meningococcal Group B Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Meningococcal Group B Vaccine Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Meningococcal Group B Vaccine Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Meningococcal Group B Vaccine Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Meningococcal Group B Vaccine Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Meningococcal Group B Vaccine Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Meningococcal Group B Vaccine Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Meningococcal Group B Vaccine Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Meningococcal Group B Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Meningococcal Group B Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Meningococcal Group B Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Meningococcal Group B Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Meningococcal Group B Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Meningococcal Group B Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Meningococcal Group B Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Meningococcal Group B Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Meningococcal Group B Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Meningococcal Group B Vaccine Sales Value and Growth Rate (2017-2028)
-
Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Pfizer Product Profiles, Application and Specification
-
Table Pfizer Meningococcal Group B Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table GSK Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table GSK Product Profiles, Application and Specification
-
Table GSK Meningococcal Group B Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
